BIOLIGHT(SZ:300246) Zheng Quan Shi Bao·2025-04-11 09:35Core Viewpoint - The 91st China International Medical Equipment Fair (CMEF) successfully attracted numerous overseas buyers despite the backdrop of U.S. tariffs, indicating resilience in the medical device industry and a shift towards exploring markets outside the U.S. [1][2] Group 1: Overseas Participation - The CMEF showcased a significant presence of international buyers from countries such as the U.S., Turkey, India, and the Middle East, countering initial concerns about reduced attendance due to U.S. tariffs [2][6] - Many overseas buyers engaged in serious discussions with Chinese exhibitors, exploring potential collaboration opportunities and even planning factory visits [6][8][10] Group 2: Impact of U.S. Tariffs - Most Chinese exhibitors reported minimal impact from U.S. tariffs, with 7 out of 10 companies indicating that their products do not export to the U.S. market [13] - For companies exporting to the U.S., the tariff impact was still considered minor, with one company noting that U.S. exports account for less than 10% of their total sales [13][14] - Some companies experienced order pauses from U.S. clients, with one reporting a value of approximately 1 million yuan in suspended orders [13] Group 3: Market Expansion Strategies - In response to U.S. tariffs, companies are actively seeking to expand into European and other international markets, with one company establishing a sales office in Dubai to cover Europe and Africa [14] - Companies are also focusing on Southeast Asia and countries involved in the Belt and Road Initiative to mitigate the loss of U.S. orders [15][16] - The Chinese government is supporting foreign trade enterprises in exploring domestic markets and enhancing their competitiveness through various initiatives [16][17]